𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Study of cell kinetics in anaplastic thyroid carcinoma transplanted to nude mice

✍ Scribed by Dr. Akira Yoshida; Masakatu Fukazawa; Hiroki Ushio; Yuji Aiyoshi; Shugo Soeda; Kunihiko Ito


Book ID
102925774
Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
980 KB
Volume
41
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


The cell kinetics of the transplantable human anaplastic thyroid carcinoma were studied in athymic nude mice using bromodeoxyuridine (BrdU) pulse labeling. In order to estimate the cell cycle time in this study, the percent labeled mitosis curve was prepared with immunoperoxidase staining using monoclonal antibody to BrdU instead of '[Hlthymidine autoradiography .

This technique was considered to be very useful because it can be done for a short term and can still be changed to the autoradiographic method.

Comparing the results in this study with already reported data on various xenografts of human carcinomas in nude mice, the tumor doubling time ( 1 17.5 hr) and the cell cycle time (23.5 hr) were rather short, but the growth fraction (54%) and the cell loss factor (68%) were nearly equivalent to the median value.

These findings suggest that the very rapid growth rate of this tumor was mainly due to the shortness of the cell cycle time.


πŸ“œ SIMILAR VOLUMES


Clonal growth of colorectal-carcinoma ce
✍ Nico J. De Both; Marcel Vermey; Nicole Groen; Winand N. Dinjens; Fred T. Bosman πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 118 KB πŸ‘ 2 views

It is generally assumed that tumor progression is a microevolutionary process in which increasingly aggressive clones, generated through genetic instability, emerge in an initially monoclonal lesion. The present study was undertaken to determine how rapidly a dominant clone will emerge from an initi

Growth inhibition of orthotopic anaplast
✍ Seungwon Kim; Yasemin D. Yazici; Samantha E. Barber; Samar A. Jasser; Mahitosh M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 609 KB

## Abstract ## Background. A preclinical evaluation of CPT‐1 (Camptosar, irinotecan) and PTK787/ZK222584, a vascular endothelial growth factor receptor (VEGFR‐2) tyrosine kinase inhibitor, as therapeutic agents against anaplastic thyroid carcinoma (ATC) was performed in vitro and in an orthotopic